Figure 3
From: Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Inhibition of cell growth as a function of increasing concentrations of a) CB, b) OX c) CH1 and d) BORT as applied to the ovarian cancer cell lines A2780, A2780cisR, A2780ZD0473R and SKOV-3. Cell survival fractions following treatment with increasing concentrations of drugs for 72Â h were determined using MTT assay and spectrophotometric analysis. Error bars represent the standard deviation.